Join the Leaders Making Gaming’s Next Big Deals. GamesBeat NEXT brings 500+ executives, CEOs, founders, and investors to San Francisco, November 2–3, to shape the future of gaming, entertainment, and AI. Connect with industry leaders, forge strategic partnerships, and close deals that move business forward. Be in the room. Get your ticket.
Colossal Biosciences made its name with an eye-catching mandate: It wants to “bring back” extinct species, using DNA extracted from what remains of the direwolf, the woolly mammoth, the thylacine and rebuilding it via their modern relatives. But during a tour of its headquarters in Dallas, I had the chance to ask a question that’s been on my mind since the news broke: Why?
I don’t just mean, “Why do this?” — I wanted to know what benefit Colossal’s research could have for us here in the modern world. Bringing back the wooly mammoth sounds scientifically edifying, but what would we do with it once it’s here?
Keep Reading with GB MAX
Get the full story — and the intelligence behind it.
GB MAX members get complete articles, full transcripts, in-depth analysis, and exclusive reporting and conversations — plus access to private editorial conversations and exclusive events. Join today and receive a complimentary VIP ticket to GamesBeat Next, November 2–3 in San Francisco.
